RECRUITING

A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD

Description

This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.

Conditions

AsthmaCOPD (Chronic Obstructive Pulmonary Disease)
Talk to us

Related Conditions:

AsthmaCOPD (Chronic Obstructive Pulmonary Disease)

Study Overview

On this page

Study Details

Study overview

This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.

A Phase 1 First in Human, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GB-0895 in Adults With Mild to Moderate Asthma or Single Dose in Chronic Obstructive Pulmonary Disease (COPD)

A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD

Condition
Asthma
Intervention / Treatment

-

Contacts and Locations

DeLand

Alcanza, DeLand, Florida, United States, 32720

Miami

Miami Research Institute of South Florida, Miami, Florida, United States, 33173

Orlando

Omega Research, Orlando, Florida, United States, 32808

Saint Paul

Nucleus Network, Saint Paul, Minnesota, United States, 55114

Winston Salem

Southeastern Research Center, Winston Salem, North Carolina, United States, 27103

Tomball

DM Clinical Research, Tomball, Texas, United States, 77375

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 80 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Generate Biomedicines,

    Study Record Dates

    2027-05